People not infected with HIV can take a daily pill to prevent themselves from contracting the virus, a proven strategy called pre-exposure prophylaxis (PrEP). But…
Comments closedCategory: Uncategorized
The high-profile patent fight over who invented a key feature of the genome editor CRISPR has been resurrected. The 3-year-old battle, which a U.S. appeals court appeared…
Comments closed
A researcher terminated by Emory University in Atlanta for allegedly not disclosing funding and ties to institutions in China is forcefully disputing the charges. And neuroscientist Li…
Comments closed
Top CRISPR researchers at two University of California (UC) campuses have teamed up with pharmaceutical giant GlaxoSmithKline (GSK) to form a new laboratory in San…
Comments closed
In a bold rejection of the widespread sentiment—and regulations in many countries—that no one should alter the genome of a human embryo and transfer it…
Comments closed
Four prominent Chinese bioethicists have published an unusually frank and critical assessment of their country’s handling of biomedical research in the wake of what they…
Comments closed
The Democratic Republic of the Congo (DRC) will expand its use of the experimental Ebola vaccine that more than 110,000 have already received to try…
Comments closed
There’s an “urgent need” to create a transparent global registry that would list all experiments related to human genome editing, an expert committee convened to…
Comments closed
BOSTON—There’s no question that a simple regimen of a single daily pill can slash HIV infections in people at risk. But although millions of people…
Comments closed